Zydus Cadila has received the Food and Drug Administration’s green light for doxorubicin hydrochloride liposome injection, which is indicated for the treatment of such cancers as ovarian cancer, AIDS-related Kaposi’s sarcoma and multiple myeloma.
Lupin is offering leflunomide tablets, which are indicated for the treatment of adults with active rheumatoid arthritis.
The Food and Drug Administration has given its stamp of approval to Zydus Cadila for midodrine hydrochloride tablets, which are indicated to treat orthostatic hypotension, or symptoms of low blood pressure when standing.
Pfizer expects to know by the end of October if its COVID-19 vaccine works, although it isn't known if Americans will receive it before 2021.
The Food and Drug Administration has granted clearance to Zydus Cadila for sevelamer carbonate tablets, which are indicated for patients with chronic kidney disease who are on dialysis to control their phosphorus levels.
GlaxoSmithKline and Innoviva have received the Food and Drug Administration’s clearance for a new indication for Trelegy Ellipta, which is used for the treatment of asthma in patients aged 18 years and older.
The Food and Drug Administration has given thumbs up to Indoco Remedies for olanzapine tablets, which are indicated for the treatment of schizophrenia and bipolar disorder, in several dosage strengths.
Alembic Pharmaceuticals is introducing its adapalene gel 0.3%, a generic to Differin Gel 0.3%, which is indicated to treat acne vulgaris in patients 12 years old and older.
Procter & Gamble has promoted a longtime executive to the president of North American sales — Monica Turner, and also added Debra Lee to its board of directors.
Sun Pharmaceutical is introducing delayed-release pantoprazole oral suspension, which is the first generic of Pfizer’s Protonix oral delayed-release suspension.
The Food and Drug Administration has given Aurobindo Pharma’s joint venture, Eugia Pharma, the green light for tamoxifen citrate tablets, which are indicated for the treatment of metastatic breast cancer in women and men.
The Food and Drug Administration has given Aurobindo the green light for methocarbamol tablets, which are indicated for the treatment of painful musculoskeletal conditions.
Lupin is offering zileuton extended-release tablets, which are indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.
Pfizer will provide contract manufacturing services at Pfizer’s McPherson, Kan. facility to manufacture and supply remdesivir for Gilead.
The Food and Drug Administration has given its blessing to Aurobindo for two generics — Novartis' Gleevec and ANI's Arimbex.
Perrigo is acquiring Eastern European OTC skin care and hair loss treatment brands Emolium, Iwostin and Loxon from Sanofi for roughly $23 million.
Patients with Parkinson’s disease will soon have a new generic to treat their condition — Zydus Cadila's carbidopa and levodopa extended-release capsules.
DSN spoke with Ken Paulino, head of Vaxserve at Sanofi Pasteur, about the company’s capabilities in helping retail pharmacies manage their immunization efforts.
The Food and Drug Administration has cleared Aurobindo’s generic of Merck's Singulair oral granules, which are indicated to treat asthma, exercise-induced bronchoconstriction, and certain other allergies such as rhinitis.
Sun Pharma has acquired Canada-based Aquinox Pharmaceuticals for $8.2 million through its subsidiary Taro, according to a report.